Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Developmental toxicity / teratogenicity

Currently viewing:

Administrative data

Endpoint:
developmental toxicity
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1970-06-12 to 1971-10-13
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
test procedure in accordance with generally accepted scientific standards and described in sufficient detail

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1971
Report date:
1971

Materials and methods

Test guideline
Qualifier:
no guideline followed
Principles of method if other than guideline:
The three-generation reproduction study was performed in 1971; there was no test guideline for such test available at that time.
GLP compliance:
not specified

Test material

Constituent 1
Reference substance name:
Decanoic acid, 2-(1-carboxyethoxy)-1-methyl-2-oxoethyl ester, sodium salt
Cas Number:
13557-74-9
IUPAC Name:
Decanoic acid, 2-(1-carboxyethoxy)-1-methyl-2-oxoethyl ester, sodium salt
Specific details on test material used for the study:
SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material: 12A 5022

Test animals

Species:
rat
Strain:
Sprague-Dawley
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Charles River Breeding Laboratories, Inc.
- Females (if applicable) nulliparous and non-pregnant: Yes
- Age at study initiation: Day 28
- Fasting Period Prior to Study: No
- Housing: Individually housed prior to study
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: 7 days

Administration / exposure

Route of administration:
oral: feed
Vehicle:
unchanged (no vehicle)
Details on exposure:
PREPARATION OF DOSING SOLUTIONS:

DIET PREPARATION
- Rate of preparation of diet (frequency): once
- Mixing appropriate amounts with (Type of food): The experimental diets were prepared by grinding appropriate amounts of the test material with a small quantity of the basal ration (Purina Laboratory Chow-Meal) in a mortar and pestle and mixing the resultant blend in a Hobart-Dayton mixer with enough basal ration to make a 6000-g batch of the desired concentration. All diets were fortified with USP cod liver oil at a concentration of 1%
Details on mating procedure:
- M/F ratio per cage: 1 M/1 F
- Length of cohabitation: 10 day
- Proof of pregnancy: Not specified
Duration of treatment / exposure:
Day 28 of F0 generation - end of study (weaning of F3 pups)
Frequency of treatment:
Daily
Doses / concentrations
Dose / conc.:
20 000 ppm
Remarks:
Diet containing 2% of sodium stearoyl lactylate.

However, during the first six weeks of the study, rats were fed 60% of these concentrations as they eat more in proportion to body weight than subsequently.
No. of animals per sex per dose:
20
Control animals:
yes
Details on study design:
Original parent rats (F0) were bred twice; the F1A pups were sacrificed at birth and part of each litter was examined either for skeletal abnormalities or for visceral changes. F1B pups were reared to weaning and pups from each litter were taken to constitute the next group of breeders. F1B rats were bred twice, and both F2A and F2B litters were reared to weaning. F2B pups were then distributed into new groups to breed the F3 generations.

Examinations

Maternal examinations:
CAGE SIDE OBSERVATIONS: Yes
- Time schedule: Daily

BODY WEIGHT: Yes
- Time schedule for examinations: Weekly, Sacrifice

FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study):
- Mean weekly food intake measured
Ovaries and uterine content:
The ovaries and uterine content was examined after termination: Yes
Examinations included:
- Gravid uterus weight: No
- Number of corpora lutea: No
- Number of implantations: Yes
- Number of early resorptions: No
- Number of late resorptions: No
- Other: Ovary Weights
Fetal examinations:

- Soft tissue examinations: Yes
- Skeletal examinations: Yes

Results and discussion

Results: maternal animals

General toxicity (maternal animals)

Clinical signs:
no effects observed
Description (incidence and severity):
All maternal rats survived their portion of the study and were in good condition throughout.
Dermal irritation (if dermal study):
not examined
Mortality:
no mortality observed
Description (incidence):
All maternal rats survived their portion of the study and were in good condition throughout.
Body weight and weight changes:
no effects observed
Description (incidence and severity):
There were no significant differences in any of the maternal generations.
Food consumption and compound intake (if feeding study):
no effects observed
Description (incidence and severity):
There were no significant differences in any of the maternal generations.
Food efficiency:
not examined
Water consumption and compound intake (if drinking water study):
not examined
Ophthalmological findings:
not examined
Haematological findings:
not examined
Clinical biochemistry findings:
not examined
Urinalysis findings:
not examined
Behaviour (functional findings):
not examined
Immunological findings:
not examined
Organ weight findings including organ / body weight ratios:
no effects observed
Description (incidence and severity):
The gonadal weights between treated and control groups were comparable to one another.
Gross pathological findings:
no effects observed
Description (incidence and severity):
At necropsy no maternal generations showed gross abnormalities.
Neuropathological findings:
not examined
Histopathological findings: non-neoplastic:
effects observed, non-treatment-related
Description (incidence and severity):
None of the histopathological findings were to be ascribed to administration of sodium capryl lactylate, other than the questionable significance of the cortical cyst incidence in the kidneys of the females.
Histopathological findings: neoplastic:
not examined
Other effects:
not examined

Maternal developmental toxicity

Number of abortions:
not examined
Pre- and post-implantation loss:
no effects observed
Description (incidence and severity):
Mean testis and ovary weights and mean total uterine implantation sites were respectively comparable among the groups.
Total litter losses by resorption:
not examined
Early or late resorptions:
not examined
Dead fetuses:
no effects observed
Description (incidence and severity):
Stillborn pups examined in the group that received test material were grossly normal.
Changes in pregnancy duration:
no effects observed
Description (incidence and severity):
There was no significant differences observed in the number of gestation days between control and treated dams.
Changes in number of pregnant:
no effects observed
Description (incidence and severity):
No significant difference between groups.
Other effects:
not examined

Effect levels (maternal animals)

Key result
Dose descriptor:
NOAEL
Effect level:
20 000 ppm
Based on:
test mat.
Basis for effect level:
body weight and weight gain
changes in pregnancy duration
clinical signs
dead fetuses
early or late resorptions
effects on pregnancy duration
food consumption and compound intake
gross pathology
histopathology: non-neoplastic
mortality
organ weights and organ / body weight ratios
pre and post implantation loss

Maternal abnormalities

Key result
Abnormalities:
no effects observed

Results (fetuses)

Fetal body weight changes:
not examined
Reduction in number of live offspring:
no effects observed
Description (incidence and severity):
No significant difference was found.
Changes in sex ratio:
no effects observed
Description (incidence and severity):
No significant difference was found.
Changes in litter size and weights:
no effects observed
Description (incidence and severity):
No significant difference was found.
Changes in postnatal survival:
no effects observed
Description (incidence and severity):
There was slightly lower survival at five and twenty-one days which is believed to be because of an intercurrent infection of undetermined nature.
External malformations:
not examined
Skeletal malformations:
effects observed, non-treatment-related
Description (incidence and severity):
Skeletal anomalies seen in test group pups during any of the generations were not in frequencies high enough to be meaningful.
Visceral malformations:
effects observed, non-treatment-related
Description (incidence and severity):
Visceral anomalies seen in test group pups during any of the generations were not in frequencies high enough to be meaningful.
Other effects:
not examined

Effect levels (fetuses)

Key result
Dose descriptor:
NOAEL
Effect level:
20 000 ppm
Based on:
test mat.
Sex:
male/female
Basis for effect level:
reduction in number of live offspring
changes in sex ratio
changes in postnatal survival
skeletal malformations
visceral malformations

Fetal abnormalities

Key result
Abnormalities:
no effects observed

Overall developmental toxicity

Key result
Developmental effects observed:
no

Any other information on results incl. tables

None of the histopathological observations made in F3 generation were believed to be related to the administration of the test substance sodium capryl lactylate under the conditions of this study other than the questionable significance of the cortical cyst incidence in the kidneys of females.

The full tables of litter data for each generation are below.

F1A Litter Information

Observations

Control

Sodium Capryl Lactylate (2%)

Litters per group

18/20

17/20

Total live pups

207

177

Total Stillborn

1

1

Live pups per litter

11.5

10.4

Mean body weights (g) of live pups

5.53

5.64

Number of male pups

109

90

Number of female pups

98

87

 

F1B Litter Information

Observations

Control

Sodium Capryl Lactylate (2%)

Litters per group

12/20

12/20

Total live pups

 

 

     Birth

151

125

     Day 5

96

62

     Weaning

79

53

Total Stillborn

0

1

Live pups per litter

12.6

10.4

Per cent survival at day 5

63.6

49.6

100X weaning survival/ 5 day survival

86.8

93.0

Mean body weights (g) of live pups at

 

 

    Birth

5.90

6.02

    Day 5

9.65

9.18

    Weaning

41.5

32.8

 

F2A Litter Information

Observations

Control

Sodium Capryl Lactylate (2%)

Litters per group

19/19

19/20

Total live pups

 

 

     Birth

221

212

     Day 5

127

108

     Weaning

81

74

Total Stillborn

1

2

Live pups per litter

11.6

11.2

Per cent survival at day 5

57.5

50.9

100X weaning survival/ 5 day survival

68.6

71.9

Mean body weights (g) of live pups at

 

 

    Birth

5.96

6.10

    Day 5

7.43

7.69

    Weaning

33.9

34.0

 

F2B Litter Information

Observations

Control

Sodium Capryl Lactylate (2%)

Litters per group

17/19

20/20

Total live pups

 

 

     Birth

210

233

     Day 5

97

89

     Weaning

63

68

Total Stillborn

0

1

Live pups per litter

12.4

11.6

Per cent survival at day 5

46.2

38.2

100X weaning survival/ 5 day survival

72.4

78.2

Mean body weights (g) of live pups at

 

 

    Birth

5.91

5.91

    Day 5

8.34

77.76

    Weaning

39.5

32.0

 

F3A Litter Information

Observations

Control

Sodium Capryl Lactylate (2%)

Litters per group

14/20

18/20

Total live pups

 

 

     Birth

143

199

     Day 5

82

164

     Weaning

68

147

Total Stillborn

0

1

Live pups per litter

10.2

11.1

Per cent survival at day 5

57.6

82.4

100X weaning survival/ 5 day survival

82.9

89.6

Mean body weights (g) of live pups at

 

 

    Birth

5.73

5.72

    Day 5

8.89

8.57

    Weaning

37.5

33.1

 

F3B Litter Information

Observations

Control

Sodium Capryl Lactylate (2%)

Litters per group

16/20

17/20

Total live pups

 

 

     Birth

167

198

     Day 5

115

123

     Weaning

101

97

Total Stillborn

1

1

Live pups per litter

11.1

11.6

Per cent survival at day 5

68.9

62.1

100X weaning survival/ 5 day survival

87.8

78.6

Mean body weights (g) of live pups at

 

 

    Birth

6.03

5.90

    Day 5

9.76

8.20

    Weaning

36.7

33.4

 

Applicant's summary and conclusion

Conclusions:
There were no differences among control group and those fed sodium capryl lactylate that could be ascribed to treatment. Mortality, body weights, food intake, gross necropsy (gonad weights) and litter data were collected. Sodium capryl lactylate does not adversely effect development in albino rats through three generations.
Executive summary:

A three-generation reproductive study in albino Sprague-Dawley Rats was performed on the test substance sodium capryl lactylate. Mortality, body weights, food intake, gross necropsy (gonad weights) and litter data were collected. There were no differences among control group and those fed sodium capryl lactylate that could be ascribed to treatment. The author noted there was a questionable significance of cortical cyst incidence in the kidneys of females. Sodium capryl lactylate does not adversely affect development in albino rats through three generations.